Search Results - "melanoma"
Suggested Topics within your search.
Suggested Topics within your search.
- Melanoma 4
- immunology
- therapy 4
- Immunotherapy 3
- methods 3
- Antineoplastic Agents 2
- Cancer 2
- Immunological aspects 2
- Neoplasms 2
- therapeutic use 2
- Adjuvants, Immunologic 1
- Adoptive Transfer 1
- Antibodies, Monoclonal 1
- Antigen Presentation 1
- Antigens, Viral 1
- Antineoplastic agents 1
- CD8-Positive T-Lymphocytes 1
- CTLA-4 Antigen 1
- Cancer Vaccines 1
- Cancer vaccines 1
- Cell Cycle Checkpoints 1
- Drug targeting 1
- Granulocyte-Macrophage Colony-Stimulating Factor 1
- Herpesvirus 1, Human 1
- Immunotherapy, Adoptive 1
- Indicators and Reagents 1
- Melanocytes 1
- Oncolytic Virotherapy 1
- Pigmentation Disorders 1
- Pigmentation disorders 1
-
1
Disorders of pigmentation melanoma /
Published 2014Table of Contents: “…Contents: Melanocyte development -- Key factors regulating lineage development -- Relationships to pigmentation diseases -- MITF -- IV-induced pigmentation -- Melanoma-genesis -- Melanoma oncogene discovery -- BRAF-targeted therapy -- Immunotherapy -- Red pigment and melanoma-genesis.…”
Get full text
Series
Electronic Video -
2
Immune checkpoint blockade in melanoma
Published 2017Table of Contents: “…Contents: Checkpoint inhibition in melanoma -- Immunotherapy in the adjuvant setting -- Biomarkers of immune response -- The future of immunotherapy in melanoma -- Targeting release of cancer antigens -- Targeting cancer antigen presentation -- Targeting priming and activation of the immune system -- Targeting trafficking and infiltration of T-cells -- Targeting recognition and killing of cancer cells.…”
Get full text
Series
Electronic Video -
3
Cancer vaccines part 1 of 2 /
Published 2015Table of Contents: “…Contents: The hallmarks of cancer -- Categories of cancer-associated antigens -- Viral & non-viral cancers: vaccine targets -- Immunotherapeutics -- Immunologic reagents approved for cancer therapy -- Clinical outcome based on immune response -- CTL-based therapy -- Virus-specific CTL adoptive transfer therapy -- Immunotherapy for Melanoma.…”
Get full text
Series (Immunotherapy of cancer)
Series (Vaccines)
Electronic Video -
4
Talimogene laherparepvec first-in-class oncolytic immunotherapy /
Published 2016Table of Contents: “…Contents: Causing tumour cell lysis -- Initiating a specific systemic immune response -- T-VEC as an oncolytic HSV-1 strain -- Assessing cancer immunotherapy through melanoma -- Applicability of oncolytic viral therapy to various cancers.…”
Get full text
Series
Electronic Video